Analyzing Elanco Animal Health (NYSE:ELAN) & Hypera (OTCMKTS:HYPMY)
Analyzing Elanco Animal Health (NYSE:ELAN) & Hypera (OTCMKTS:HYPMY)
Elanco Animal Health (NYSE:ELAN – Get Rating) and Hypera (OTCMKTS:HYPMY – Get Rating) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.
Elanco Animal Health（紐約證券交易所代碼：ELAN — 獲取評級）和 Hypera（OTCMKTS: HYPMY — 獲取評級）都是中型醫療公司，但哪隻是優勢股？我們將根據兩家企業的估值、風險、股息、機構所有權、分析師建議、盈利能力和收益進行對比。
Institutional and Insider Ownership
機構所有權和內部所有權
0.1% of Hypera shares are owned by institutional investors. 0.6% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
0.1％的Hypera股票由機構投資者持有。0.6％的Elanco Animal Health股票由公司內部人士擁有。強大的機構所有權表明對沖基金、大型基金經理和捐贈機構認爲，從長遠來看，公司的表現將優於市場。
Analyst Recommendations
分析師建議
This is a breakdown of current recommendations and price targets for Elanco Animal Health and Hypera, as reported by MarketBeat.
據MarketBeat報道，這是Elanco Animal Health和Hypera目前的建議和目標價格的明細。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Elanco Animal Health | 1 | 6 | 0 | 0 | 1.86 |
| Hypera | 0 | 1 | 1 | 0 | 2.50 |
| 賣出評級 | 持有評級 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| Elanco 動物健康 | 1 | 6 | 0 | 0 | 1.86 |
| Hypera | 0 | 1 | 1 | 0 | 2.50 |
Elanco Animal Health currently has a consensus price target of $16.50, suggesting a potential upside of 74.42%. Given Elanco Animal Health's higher probable upside, research analysts plainly believe Elanco Animal Health is more favorable than Hypera.
Elanco Animal Health目前的共識目標股價爲16.50美元，表明潛在的上漲空間爲74.42％。鑑於Elanco Animal Health可能有更高的上漲空間，研究分析師顯然認爲Elanco Animal Health比Hypera更有利。
Risk and Volatility
風險和波動性
Elanco Animal Health has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Hypera has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.
Elanco Animal Health的beta值爲0.92，這意味着其股價的波動性比標準普爾500指數低8％。相比之下，Hypera的beta值爲0.74，這意味着其股價的波動性比標準普爾500指數低26％。
Profitability
盈利能力
This table compares Elanco Animal Health and Hypera's net margins, return on equity and return on assets.
該表比較了Elanco Animal Health和Hypera的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Elanco Animal Health | -1.74% | 7.57% | 3.50% |
| Hypera | N/A | N/A | N/A |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| Elanco 動物健康 | -1.74% | 7.57% | 3.50% |
| Hypera | 不適用 | 不適用 | 不適用 |
Valuation & Earnings
估值與收益
This table compares Elanco Animal Health and Hypera's gross revenue, earnings per share (EPS) and valuation.
該表比較了Elanco Animal Health和Hypera的總收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Elanco Animal Health | $4.42 billion | 1.05 | -$78.00 million | ($0.15) | -63.06 |
| Hypera | $793.81 million | 5.76 | $251.25 million | N/A | N/A |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股收益 | 市盈率 | |
| Elanco 動物健康 | 44.2 億美元 | 1.05 | -78.00 萬美元 | (0.15 美元) | -63.06 |
| Hypera | 7.9381 億美元 | 5.76 | 2.5125 億美元 | 不適用 | 不適用 |
Hypera has lower revenue, but higher earnings than Elanco Animal Health.
Hypera的收入較低，但收入高於Elanco Animal Health。
About Elanco Animal Health
關於 Elanco 動物健康
(Get Rating)
（獲取評級）
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants &
Elanco Animal Health, Inc. 創新、開發、製造和銷售寵物和農場動物產品。它提供以下四個類別的產品：伴侶動物疾病預防、伴侶動物療法、Food Animal Future Protein & Health 以及食用動物反芻動物和豬。伴侶動物疾病預防類別根據適應症、種類和配方，從事伴侶動物領域最廣泛的寄生蟲殺滅劑產品組合，其產品可保護寵物免受蠕蟲、跳蚤和蜱的侵害。Companion Animal Therapeutics 類別提供了跨物種、作用方式、適應症和疾病階段的廣泛疼痛和骨關節炎產品組合的詳細信息。Food Animal Future Protein & Health 類別包括疫苗、營養酶和動物專用抗生素，滿足對蛋白質不斷增長的需求，包括家禽和水產養殖生產中的創新產品，對動物健康產品的需求超過了整個行業的增長。它還專注於開發促進食用動物健康的功能性營養健康產品，包括酶、益生菌和益生元。食用動物反芻動物和
About Hypera
關於 Hypera
(Get Rating)
（獲取評級）
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.
Hypera S.A. 作爲一家制藥公司在巴西運營。它提供 Adacne、Addera、apri、AmpliumG 下的處方產品，請 Celestamine、Celestone、Celestone Soluspan、Cizax、diciprax、Dirmotil Fusid、Digedrat、diprosalic、diprosone、diprosone、diprosalic、diprosone、diprosone、Diprosan、Emprol XR、Flow、Garasone、Halobex、Librox panon、moon、Lydian、macrodantin、maxSulid、milgamma、Mioflex — A、nesina、Novotram、oximax、predal、pressaliv、Quadridem、Rizi M、softalm、tacroz、tinodin、umma 和 velunid 品牌。該公司還提供Mantecorp Skincare品牌的皮膚化妝品；以及Apracur、Benegrip、Coristina d、Engov、Epocler、Estomazil和其他品牌的消費者健康產品。此外，它還提供 Tamarine、Vitasay、biotonico Fontoura 和 Zero-Cal 品牌的營養和維生素補充產品；以及 Neo qui'mica、雙氯芬酸鈉、羥嗪、二吡侖、布洛芬、洛沙坦鉀、Mal 右氯苯那敏、萘普生、撲熱息痛、二氯芬酸鈉、氯雷他達的類似和仿製藥物品牌名稱：Omeprazole、Tadalaphyl 和 Desogestrel 等品牌。該公司前身爲 Hypermarcas S.A.，並於 2018 年 2 月更名爲 Hypera S.A.。Hypera S.A. 總部位於巴西聖保羅。
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收《Elanco 動物健康日報》的新聞和評級 -在下面輸入您的電子郵件地址，即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Elanco Animal Health及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。